Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Achilles Therapeutics
Achilles Therapeutics
(ACHL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mk3475
pancreatic ductal carcinoma
,
mycoses
,
squamous cell carcinoma
,
merkel cell carcinoma
,
mycosis fungoides
,
squamous cell neoplasms
,
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
sarcoma
,
breast neoplasms
,
alveolar soft part sarcoma
,
brain neoplasms
,
triple negative breast neoplasms
,
hodgkin disease
,
non-small-cell lung carcinoma
,
lung neoplasms
,
renal cell carcinoma
,
carcinoma
,
neoplasms
,
melanoma
,
skin neoplasms
,
neoplasm metastasis
,
urologic neoplasms
,
urinary bladder neoplasms
,
urogenital neoplasms
,
transitional cell carcinoma
,
urologic diseases
,
neoplasms by site
,
urinary bladder diseases
,
male urogenital diseases
,
female urogenital diseases
,
urogenital diseases
,
endometrial neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use